Similarly, recurrent CNTNAP2 alterations were reported in GBMs and an oligodendroglioma, often leading to reduced protein expression, CNTNAP2 expression was associated with poor overall survival both in univariate and multivariate analyses, and its increased expression led to decreased proliferation and increased apoptosis in GBM cells24. This evidence concerns the gene CNTNAP2 and oligodendroglioma.